Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides

Details for Australian Patent Application No. 2005338035 (hide)

Owner Idera Pharmaceuticals, Inc.

Inventors Yu, Dong; Agrawal, Sudhir; Kandimalla, Ekambar R.

Agent Freehills

Pub. Number AU-B-2005338035

PCT Pub. Number WO2007/055704

Filing date 7 November 2005

Wipo publication date 18 May 2007

Acceptance publication date 7 June 2012

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/00 (2006.01) Mutation or genetic engineering

C12N 15/117 (2010.01) Mutation or genetic engineering - Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs

C12N 15/88 (2006.01) Mutation or genetic engineering

Event Publications

22 May 2008 PCT application entered the National Phase

  PCT publication WO2007/055704 Priority application(s): WO2007/055704

7 June 2012 Application Accepted

  Published as AU-B-2005338035

4 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005338050-Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides

2005338024-Flame resistant fiber blends, fire and heat barrier fabrics and related process